Biocomposites expands its product portfolio with the launch of SYNICEM™ spacers in the UK

  • SYNICEM™ hip, knee and shoulder spacers are preformed and loaded with gentamicin to maintain space and aid treatment of infection
  • Already successfully used in UK patients as part of their infection treatment strategies

Keele, UK, 21 November 2023 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to announce the launch of SYNICEMTM hip, knee and shoulder preformed spacers in the United Kingdom, and their successful use in patients undergoing joint surgery.

Read more…

© Optimum Strategic Communications.